Low Quantity of Opioids Used After ED Discharge for Acute Pain
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 15, 2024 -- For patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published online July 15 in CMAJ, the journal of the Canadian Medical Association.
Raoul Daoust, M.D., from Sacré-Coeur Hospital in Montreal, and colleagues conducted a prospective, multicenter cohort study involving 2,240 adults (mean age, 51 years) with an acute pain condition present for less than two weeks who were discharged from the emergency department with an opioid prescription. Participants completed a pain medication diary for real-time recording of all analgesics consumed during a 14-day follow-up.
The researchers found that participants consumed a median of five morphine 5-mg tablet equivalents over 14 days, with significant variation seen across pain conditions. Overall, 63 percent of the opioid tablets prescribed were unused. Those experiencing renal colic or abdominal pain required fewer opioid tablets (eight morphine 5-mg tablet equivalents) than those with fractures, back pain, neck pain, or other musculoskeletal pain (24, 21, 17, and 16 tablets, respectively) to meet the opioid need of 80 percent of patients for two weeks.
"Our findings may provide guidance to enable clinicians to prescribe lower quantities of opioids and provide them in even smaller portions tailored to the specific cause of acute pain, thereby allowing adequate pain relief while reducing the risk of opioid misuse," the authors write.
One author disclosed ties to the medical device industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-16 01:15
Read more
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
- Geographic Position Influences Climate Change Risk Perception of Emergency Medical Services
- Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
- Topical Human Platelet Extract Noninferior for Photoaging of Hands
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions